Evidence map›Paper›PMID 39438987›Full record

ArticleMicrobiome2024

The Staphylococcus aureus-antagonizing human nasal commensal Staphylococcus lugdunensis depends on siderophore piracy.

Ralf Rosenstein, Benjamin O Torres Salazar, Claudia Sauer, Simon Heilbronner, Bernhard Krismer, Andreas Peschel

Abstract read
In one paragraph

Article in Microbiome, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Methicillin-resistant Staphylococcus aureus.Nature reviews. Disease primers · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. High-resolutionMicrobial genomics · 2025
    Article
  9. Journal of bacteriology · 2025
    Review
  10. Article
  11. Microbiology (Reading, England) · 2025
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ralf Rosenstein *Cluster of Excellence EXC 2124 "Controlling Microbes to Fight Infections (CMFI)", University of Tübingen, Tübingen, Germany.
Benjamin O Torres Salazar *Cluster of Excellence EXC 2124 "Controlling Microbes to Fight Infections (CMFI)", University of Tübingen, Tübingen, Germany.
Claudia SauerInterfaculty Institute of Microbiology and Infection Medicine Tübingen, Infection Biology, University of Tübingen, Auf der Morgenstelle 28, Tübingen, 72076, Germany.
Simon HeilbronnerCluster of Excellence EXC 2124 "Controlling Microbes to Fight Infections (CMFI)", University of Tübingen, Tübingen, Germany.ORCID 0000-0002-6774-2311
Bernhard KrismerCluster of Excellence EXC 2124 "Controlling Microbes to Fight Infections (CMFI)", University of Tübingen, Tübingen, Germany. b.krismer@uni-tuebingen.de.ORCID 0000-0002-9505-8285
Andreas PeschelCluster of Excellence EXC 2124 "Controlling Microbes to Fight Infections (CMFI)", University of Tübingen, Tübingen, Germany.ORCID 0000-0002-3209-8626

Funding

Deutsche Forschungsgemeinschaft Cluster of Excellence EXC2124Deutsche Forschungsgemeinschaft GRK1708
6 · The paper itself

Abstract

backgroundBacterial pathogens such as Staphylococcus aureus colonize body surfaces of part of the human population, which represents a critical risk factor for skin disorders and invasive infections. However, such pathogens do not belong to the human core microbiomes. Beneficial commensal bacteria can often prevent the invasion and persistence of such pathogens by using molecular strategies that are only superficially understood. We recently reported that the commensal bacterium Staphylococcus lugdunensis produces the novel antibiotic lugdunin, which eradicates S. aureus from the nasal microbiomes of hospitalized patients. However, it has remained unclear if S. lugdunensis may affect S. aureus carriage in the general population and which external factors might promote S. lugdunensis carriage to enhance its S. aureus-eliminating capacity.

resultsWe could cultivate S. lugdunensis from the noses of 6.3% of healthy human volunteers. In addition, S. lugdunensis DNA could be identified in metagenomes of many culture-negative nasal samples indicating that cultivation success depends on a specific bacterial threshold density. Healthy S. lugdunensis carriers had a 5.2-fold lower propensity to be colonized by S. aureus indicating that lugdunin can eliminate S. aureus also in healthy humans. S. lugdunensis-positive microbiomes were dominated by either Staphylococcus epidermidis, Corynebacterium species, or Dolosigranulum pigrum. These and further bacterial commensals, whose abundance was positively associated with S. lugdunensis, promoted S. lugdunensis growth in co-culture. Such mutualistic interactions depended on the production of iron-scavenging siderophores by supportive commensals and on the capacity of S. lugdunensis to import siderophores. Video Abstract

conclusionsThese findings underscore the importance of microbiome homeostasis for eliminating pathogen colonization. Elucidating mechanisms that drive microbiome interactions will become crucial for microbiome-precision editing approaches.

Indexed as

NoseSiderophoresStaphylococcal InfectionsStaphylococcus aureusStaphylococcus lugdunensisAdultCarrier StateFemaleHealthy VolunteersHumansMaleMicrobiotaMiddle AgedSymbiosisSiderophoresBacteriocinInter-species competitionIron limitationNasal commensalsNasal microbiomeNutritional immunitySiderophoreStaphylococcus aureus

Identifiers

PMID39438987
PMCPMC11495082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.